Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Data Page
  • Published:

2009: Turning the corner

Nature Biotechnology volume 28, page 116 (2010)Cite this article

Subjects

Access through your institution
Buy or subscribe

Despite the shaky start to 2009, the biotech sector regained its financial footing. Biotech indices were up, as were offerings and partnership monies. Excluding collaborations, the sector raised a total of $24.3 billion. Although initial public offerings showed signs of resuscitation (at least 13 more companies are now in the queue), follow-on financings came in above $6 billion—the second-best year over the past decade.

Stock market performance

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

  1. Walter Yang is research director at BioCentury,

    Walter Yang

Authors
  1. Walter Yang
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yang, W. 2009: Turning the corner. Nat Biotechnol 28, 116 (2010). https://doi.org/10.1038/nbt0210-116

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/nbt0210-116

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research